Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 2

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

AZD1386 / AstraZeneca

NCT01019928 / 2008-007420-26: Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)


	Jan 2013 - Jan 2013:

Completed

Europe

AZD1386, Placebo to AZD1386

AstraZeneca

Sensitivity in Esophagus

01/11

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites